Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Total Equity

Arena Pharmaceuticals Total Equity Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Total Equity from 2000 to 2018.
  • Arena Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $531m a 61.01% increase of 324m year over year
  • Arena Pharmaceuticals Total Equity for the last 12 months ending September 09, 2018 was $531m a 61.01% increase of 324m year over year
  • Arena Pharmaceuticals Annual Total Equity for 2017 was $207m a 80.50% increase of 167m from 2016
  • Arena Pharmaceuticals Annual Total Equity for 2016 was $40m a -32.55% decrease of -13m from 2015
  • Arena Pharmaceuticals Annual Total Equity for 2015 was $54m a 11.57% increase of 6m from 2014
Other Balance Sheet Metrics:
  • Arena Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $610m a 44.38% increase of 271m year over year
  • Arena Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $1m a -69.22% decrease of -1m year over year
View Chart On Koyfin

Quarterly ARNA Total Equity Data

09/2018$531m
06/2018$559m
03/2018$584m
12/2017$207m
09/2017$218m
06/2017$83m
03/2017$27m
12/2016$40m
09/2016$4m
06/2016$14m

Annual ARNA Total Equity Data

2017$207m
2016$40m
2015$54m
2014$47m
2013$92m
2012$99m
2011$11m
2010$80m
2009$75m
2008$118m